Dabrafenib (GSK2118436A) is a Raf inhibitor that inhibits C-Raf and B-RafV600E (IC50=5/0.6 nM) and is ATP-competitive. Dabrafenib exhibits antitumor activity for the treatment of B-RafV600E-mutated melanoma.
Molecular Weight:
519.56
Purity:
>99.99%
CAS Number:
[1195765-45-7]
Formula:
C23H20F3N5O2S2
Target:
Raf
T1903
* VAT and and shipping costs not included. Errors and price changes excepted